Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Anti-ageing gets another boost with Napa Therapeutics launch

Juvenescence teams up with Insilico Medicines and Buck Institute

- PMLiVE

Industry appointments

Vivaldi heads up Sigilon, Pfizer Oncology loses its CMO and Zelluna appoints new CSO

- PMLiVE

Realm toppled by second mid-stage trial flop

The hypochlorous acid gel failed to show EASI score improvement compared to placebo

- PMLiVE

Your excellent marketing team: let the world know about it

Deadline of 30 August for PMEA awards fast approaching

Keytruda’s secret sauce

Merck’s position in oncology is about much more than a good product

- PMLiVE

Shock as NICE turns down Biogen’s SMA therapy

UK’s cost effectiveness watchdog says the drug’s long-term benefits are unclear

- PMLiVE

Paramount Recruitment reveals Communiqué Casino winners

Bayer’s Chris Henry and Edelman’s Nilüfer Münür win the prizes

- PMLiVE

Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland

The latest from pharma, biotech and healthcare

- PMLiVE

After Cohen payment scandal, Novartis unveils new ethics chief

New 'risk and compliance' leader has increased powers

- PMLiVE

AI company Sensyne raises £60m in IPO

University of Oxford-developed tech powers health-focused company

Dr Beth Wynne-Evans

Clinical insights bring rapid promotion at Porterhouse Medical

Porterhouse Medical is delighted to congratulate Dr Beth Wynne-Evans on her promotion to medical writer after an excellent first year in our scientific services team.  Beth graduated from St Bartholomew's...

Porterhouse Medical Group

- PMLiVE

Daily Brief: Orchard raises $150m, Astellas swoops for early-stage gene company, Amicus gets FDA Fabry approval

Gene therapy trend grows, new rival for Fabrazyme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links